Ishita Drugs & Industries share news, announcements and annual reports
BSE: 524400Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹73.80.
30 Oct: open ₹73.50, high ₹73.50, low ₹73.30
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr4,064th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 31.03
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,350
Ishita Drugs & Industries share news and announcements
527 announcements, routine notices left out, newest first. Page 9 of 11.
Nov 2017
Oct 2017
25 Oct · Compliance Certificate For The Half Year Ended September,2017
19 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....6 Oct · Statement Of Investor Complaints For The Quarter Ended September,2017
4 Oct · Annual Report For The Financial Year 2016-17 Pursuant To Regulation 34 Of SEBI(LODR) Regulation, 2015
3 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2017
30 Sep · Meeting
Aug 2017
5 Aug · Board Meeting On August 14, 2017
Jul 2017
17 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....7 Jul · Statement Of Investors Complaints For The Quarter Ended June,2017
May 2017
20 May · Board Meeting On 30Th May, 2017
Apr 2017
18 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....14 Apr · Certificate Pursuant To Regulation 40(9)Of SEBI(Listing Obligations And Disclosure Requirements) Regulations,2015
14 Apr · Certificate Pursuant To Regulation 40(9)Of SEBI(Listing Obligations And Disclosure Requirements) Regulations,2015
10 Apr · Compliance Certificate For The Period Ended March,2017
8 Apr · Statement Of Investor Complaints For The Quarter Ended March, 2017
Feb 2017
14 Feb · Limited Review Report for December 31, 2016
Jan 2017
18 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....14 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Nov 2016
14 Nov · Limited Review Report for September 30, 2016
Oct 2016
21 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....8 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Sep 2016
Aug 2016
26 Aug · Updates
Jul 2016
22 Jul · Shareholding for the Period Ended June 30, 2016
Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click ....8 Jul · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
May 2016
Apr 2016
14 Apr · Shareholding for the Period Ended March 31, 2016
Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click ....14 Apr · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Mar 2016
5 Mar · Shareholding for the Period Ended December 31, 2015
Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click ....
Feb 2016
Jan 2016
18 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Dec 2015
28 Dec · Statement of Assets & Liabilities as on September 30, 2015
Nov 2015
Oct 2015
20 Oct · Shareholding Pattern for September 30, 2015